| Patents for C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613) |
|---|
| 06/06/2013 | US20130144062 Heteroaryl carboxamides |
| 05/21/2013 | US8445476 Carbacephem β-lactam antibiotics |
| 07/24/2012 | US8227598 Heteroaryl carboxamides |
| 12/06/2011 | US8071761 Substrates for beta-lactamase and uses thereof |
| 09/15/2011 | US20110224186 Carbacephem beta-lactam antibiotics |
| 07/12/2011 | US7977378 Compositions and methods for enhancing weight-loss by cyclical administration of compounds |
| 10/28/2010 | WO2010123997A1 Carbacephem beta-lactam antibiotics |
| 09/15/2010 | CN101177426B Process for separating extracting spherosinin from gansu whin |
| 08/12/2010 | WO2010030811A3 CARBACEPHEM β-LACTAM ANTIBIOTICS |
| 03/18/2010 | WO2010030811A2 CARBACEPHEM β-LACTAM ANTIBIOTICS |
| 03/18/2010 | WO2010030810A1 Carbacephem beta-lactam antibiotics |
| 03/10/2010 | EP2161268A1 Carbacephem beta-lactam compounds for the treatment of bacterial infections |
| 02/18/2010 | US20100040548 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
| 11/25/2009 | EP1618106B1 Carbacephem beta-lactam antibiotics |
| 11/03/2009 | CA2420579C Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 01/28/2009 | EP1315701B1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 09/23/2008 | US7427680 Fluorogenic substrates for BETA-lactamase gene expression |
| 09/02/2008 | CA2379650C Process for producing a basic antibiotic inorganic acid salt, and oxalate intermediate |
| 07/08/2008 | US7396926 Compound for use in the measurement of gene expression |
| 05/14/2008 | CN101177426A Process for separating extracting spherosinin from gansu whin |
| 04/08/2008 | US7355040 Process for the preparation of cephalosporin compounds and synthetic intermediates |
| 01/10/2008 | US20080009624 Heteroaryl carboxamides |
| 10/17/2007 | CN101054376A Method of preparing 1-methyl carbon cephem and intermediate product thereof |
| 10/03/2007 | EP1448530B1 Heteroaryl carboxylic acid amides |
| 08/14/2007 | US7256288 For therapy or prophylaxis of diseases and for improving perception, concentration, learning and/or memory |
| 08/09/2007 | US20070184513 Substrates for beta-lactamase and uses thereof |
| 07/04/2007 | CN1324067C Makrolan having specific branching end group, polyester carbonate ester and polyester |
| 02/13/2007 | CA2359744C Cephalosporins and homologues preparations and pharmaceutical compositions |
| 01/04/2007 | WO2006085978A3 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression |
| 01/02/2007 | US7157575 Measuring gene expression |
| 09/19/2006 | US7109190 Carbacephem β-lactam antibiotics |
| 09/14/2006 | US20060205938 Monohydrate solvates of loracarbef |
| 08/17/2006 | WO2006085978A2 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression |
| 02/08/2006 | CN1732167A Monohydrate solvates of loracarbef |
| 01/25/2006 | EP1618106A2 Carbacephem -lactam antibiotics |
| 11/03/2005 | US20050245498 Sterically-awkward beta-lactamase inhibitors |
| 09/27/2005 | US6949650 Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 09/22/2005 | US20050209236 For therapy or prophylaxis of diseases and for improving perception, concentration, learning and/or memory |
| 08/24/2005 | EP1565462A1 Monohydrate solvates of loracarbef |
| 08/18/2005 | US20050181469 Beta-lactamase substrates having phenolic ethers |
| 08/03/2005 | CN1213144C Recombination nucleic acid molecule and application thereof |
| 07/28/2005 | US20050165229 Cyclization cepham derivative; 1,4-dihydroxylbut-1-yl side chain is cyclized to form cyclic ether, such as tetrahydrofuranyl system; acid catalyst |
| 06/02/2005 | WO2004098500A3 CARBACEPHEM ss-LACTAM ANTIBIOTICS |
| 06/02/2005 | US20050118669 Reporter genes; fluorescence activated cell sorting |
| 02/24/2005 | WO2004037163A3 STERICALLY-AWKWARD β-LACTAMASE INHIBITORS |
| 02/16/2005 | EP1385853A4 Beta-lactamase substrates having phenolic ethers |
| 01/06/2005 | US20050004095 Carbacephem beta-lactam antibiotics |
| 11/30/2004 | US6825344 Process for the preparation of cephalosporin compounds and synthetic intermediates |
| 11/30/2004 | US6825312 Polycarbonatester copolymer molding materials |
| 11/18/2004 | WO2004098500A2 CARBACEPHEM ss-LACTAM ANTIBIOTICS |
| 11/18/2004 | CA2526875A1 Carbacephem beta-lactam antibiotics |
| 10/12/2004 | US6803460 Acidification; carbonation |
| 08/25/2004 | EP1448530A1 Heteroaryl carboxylic acid amides |
| 08/10/2004 | CA2124999C Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| 08/03/2004 | CA2125001C Process for converting loracarbef dihydrate to loracarbef monohydrate |
| 06/03/2004 | WO2004046142A1 Monohydrate solvates of loracarbef |
| 06/03/2004 | CA2506872A1 Monohydrate solvates of loracarbef |
| 05/06/2004 | WO2004037163A2 STERICALLY-AWKWARD β-LACTAMASE INHIBITORS |
| 04/07/2004 | EP1405922A2 Substrates for beta-lactamase and uses thereof |
| 02/18/2004 | CN1138781C Process for recovery cephalosporin from fermentative liquid |
| 02/12/2004 | US20040030090 Polycarbonates, polyester carbonates and polyesters with special branched terminal groups |
| 02/04/2004 | EP1385853A2 Beta-lactamase substrates having phenolic ethers |
| 01/22/2004 | US20040014786 Procee for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 12/25/2003 | US20030236243 Sterically-awkward beta-lactamase inhibitors |
| 12/04/2003 | WO2002068678A3 Beta-lactamase substrates having phenolic ethers |
| 11/12/2003 | CN1454914A Makrolan having specific branching end group, polyester carbonate ester and polyester |
| 11/05/2003 | EP1359176A2 Polycarbonates, polyestercarbonates and polyesters having specific branched endgroups |
| 07/24/2003 | US20030139595 Novel process for the fermentative production of cephalosporin |
| 07/09/2003 | CN1113885C Process for producing beta-lactam derivs. |
| 06/26/2003 | US20030119085 Substrates for beta-lactamase and uses thereof |
| 06/18/2003 | CN1111410C Process for preparation of pharmaceutical composition |
| 06/04/2003 | EP1315701A1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 05/30/2003 | WO2003043991A1 Heteroaryl carboxylic acid amides |
| 04/22/2003 | US6552185 Acidifying and/or contacting with carbon dioxide followed by adsorption chromatography |
| 01/02/2003 | US20030003526 Compound for use in the measurement of gene expression |
| 10/30/2002 | EP1066294B1 Novel process for the fermentative production of cephalosporin |
| 10/29/2002 | US6472205 Expression control sequences adapted for function in eukaryotic cell, operably linked to sequence coding cytosolic beta-lactamase; screening by contacting host cell with membrane permeable, fluorescent substrate of beta-lactamase |
| 09/10/2002 | CA2087967C Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 09/06/2002 | WO2002068678A2 Beta-lactamase substrates having phenolic ethers |
| 09/06/2002 | CA2434679A1 Beta-lactamase substrates having phenolic ethers |
| 05/21/2002 | CA2215310C Substrates for beta-lactamase and uses thereof |
| 05/16/2002 | US20020058806 Cyclization cepham derivative |
| 04/09/2002 | US6369049 Treatment of mastitis |
| 03/07/2002 | WO2002018338A1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 02/12/2002 | CA2024399C Compounds |
| 02/06/2002 | EP1178049A1 Process for the preparation of cephalosporin compounds and intermediates for the synthesis of these compounds |
| 12/25/2001 | CA2058592C Antibacterial agents |
| 12/11/2001 | US6329363 Cephalosporin antibiotics |
| 09/18/2001 | US6291162 Determining amount of lactamase activity; transfecting cells with a nucleic acid having an expression control sequence linked to a secretion defective sequence; mixing cells with lactamase substrate; determine amount of cleaved substrate |
| 06/06/2001 | CN1066731C Substrates for beta-lactamase and uses thereof |
| 06/05/2001 | CA2034592C Crystalline hydrochloride of new beta-lactam antibiotic and process therefor |
| 05/23/2001 | CN1296078A Recombination nucleic acid molecule and application thereof |
| 05/16/2001 | CN1295575A Novel process for fermentative production of cephalosporin |
| 05/15/2001 | CA2196539C Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 04/17/2001 | US6218379 As antibacterial |
| 04/04/2001 | EP0817785B1 Substrates for beta-lactamase and uses thereof |
| 02/13/2001 | CA2001203C Novel antimicrobial dithiocarbamoyl quinolones |
| 01/31/2001 | CN1061349C Process for preparing loracarbff monohydrate |
| 01/30/2001 | CA2030361C 3-fluorosulfonyloxyceph-3-em displacement process |
| 01/24/2001 | CN1061046C Process for preparing cephalosporins derivants |